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Abstract
Background: Cell-free protein synthesis is not only a rapid and high throughput technology to
obtain proteins from their genes, but also provides an in vitro platform to study protein translation
and folding. A detailed comparison of in vitro protein synthesis in different cell-free systems may
provide insights to their biological differences and guidelines for their applications.
Results: Protein synthesis was investigated in vitro in a reconstituted prokaryotic system, a S30
extract-based system and a eukaryotic system. Compared to the S30 system, protein synthesis in
the reconstituted system resulted in a reduced yield, and was more cold-sensitive. Supplementing
the reconstituted system with fractions from a size-exclusion separation of the S30 extract
significantly increased the yield and activity, to a level close to that of the S30 system. Though
protein synthesis in both prokaryotic and eukaryotic systems showed no significant differences for
eukaryotic reporter proteins, drastic differences were observed when an artificial fusion protein
was synthesized in vitro. The prokaryotic systems failed to synthesize and correctly fold a significant
amount of the full-length fusion protein, even when supplemented with the eukaryotic lysate. The
active full-length fusion protein was synthesized only in the eukaryotic system.
Conclusion: The reconstituted bacterial system is sufficient but not efficient in protein synthesis.
The S30 system by comparison contains additional cellular factors capable of enhancing protein
translation and folding. The eukaryotic translation machinery may have evolved from its
prokaryotic counterpart in order to translate more complex (difficult-to-translate) templates into
active proteins.
Background
Cell-free protein synthesis has gained increasing popular-
ity as a rapid and high throughput technology to obtain
proteins from their genes [1-3]. Cell-free protein synthesis
systems often use a cell lysate from E. coli cells, rabbit
reticulocytes or wheat germ to supply the protein transla-
tion machinery and a recombinant T7 RNA polymerase to
couple transcription to translation. Perhaps the biggest
drawback of synthesizing proteins in the lysate is that the
lysate contains a large portion of the cellular proteins and
nucleic acids that are not necessarily involved in protein
synthesis. How and whether these macromolecules affect
the in vitro processes are largely unpredictable and often
unknown. For instance, proteases and nucleases in the
lysates could be inhibitory to protein synthesis. Cellular
proteins or nucleic acids in the lysates may interfere with
the functional assays and subsequent purification may be
hampered by the low amount of the synthesized protein.
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As a step closer to addressing these problems, protein
translation was reconstituted in vitro from purified com-
ponents of the E. coli translation machinery [4]. Except for
the ribosomes and tRNAs, which were purified from the E.
coli lysate, this reconstituted system, appropriately named
"the PURE system", contains purified recombinantly-
expressed proteins of all E. coli translation factors and
aminoacyl-tRNA synthetases [4]. Remarkably, this recon-
stituted system has been shown to catalyze efficient in
vitro protein synthesis [5]. Largely free of other cellular
components, the PURE system facilitates in vitro studies in
a much cleaner background than a lysate-based system.
The immediate impact of the PURE system and other sim-
ilar reconstituted systems was their superior performance
in such in vitro applications as the incorporation of unnat-
ural amino acids [6], ribosome display [7,8] and mRNA or
pure translation display [9,10], largely due to their design-
ability and their significantly reduced nuclease and pro-
tease activities.
In spite of the advantages of the PURE system, we sus-
pected that this "stripped-down" version of the protein
translation machinery would encounter problems when
"difficult" templates for translation were used. In this
study, we compared protein synthesis of several proteins
that exhibited significant differences when synthesized in
the PURE system and an S30 system. An S30 system is an
E. coli extract-based system, derived from the E. coli cell
lysate obtained after 30,000 × g centrifugation [11]. To
begin to investigate the reasons for these differences, we
added the size-separated fractions of an E. coli lysate to the
in vitro reactions of the PURE system. Our data suggest the
possibility of additional factors that further promote in
vitro protein synthesis.
Many eukaryotic proteins that fold correctly in eukaryotes
tend to misfold when expressed in E. coli. Such capability
of eukaryotes, which has evolved to accommodate the
needs for more complexity in proteins, has been attrib-
uted, at least in part, to the cooperativity of a large number
of eukaryotic chaperones and their intimate association
with translation and eukaryotic ribosomes [12]. To inves-
tigate the differences in protein synthesis between
prokaryotic and eukaryotic in vitro systems, we synthe-
sized a fusion protein consisting of two eukaryotic protein
domains, which was found to fold well in a rabbit reticu-
locyte system, but not in an E. coli system. In particular, we
asked if this fusion protein translated by E. coli ribosomes
would fold better in the presence of eukaryotic chaper-
ones. Such experiments would be difficult to perform in
vivo, as successful co-expression of a complete set of
eukaryotic chaperones in E. coli is perhaps an impossible
task by itself. We instead performed in vitro protein syn-
thesis in the S30 system to which a eukaryotic lysate or its
fractions were added. Our data illustrated striking differ-
ences in protein synthesis between prokaryotic and
eukaryotic in vitro systems.
Results and discussion
Compared to the S30 system, the prokaryotic 
reconstituted system (the PURE system) produced 
noticeably less protein, and was more cold-sensitive
Firefly luciferase (Fluc), a 61 kDa two-domain eukaryotic
protein [13], was chosen as a model protein for in vitro
synthesis. The same circular plasmid containing a T7 pro-
moter, a Shine-Dalgarno (SD) sequence before the ATG
start site and the gene for Fluc, was used as the DNA tem-
plate for in vitro protein synthesis in the PURE system, the
S30 system (S30) and the rabbit reticulocyte lysate system
(RRL) (Fig. 1). The full-length active protein was synthe-
sized in all three systems as judged by the western blot and
the activity assay (Fig. 1A &1C). A truncated Fluc product
(indicated by an asterisk * in Fig. 1A), detected by the
western blot in the PURE system and S30 but not in RRL,
was probably a product of the translation at an internal
translation start site. Consistent with this notion, fusion
of a small protein domain to the C-terminus but not the
N-terminus of Fluc shifted the truncated protein band to
a higher molecular weight (data not shown). The trun-
cated Fluc product was not detected in RRL (Fig. 1A), sug-
gesting the putative internal start site was not recognized
by the eukaryotic ribosomes. The lower yield in RRL com-
pared to that of S30 was probably due to the fact that no
Kozak sequence was present in the translation initiation
site of the Fluc gene [14].
Significantly less protein and lower activity were observed
in the PURE system than in S30 for Fluc and some other
proteins (Fig. 1A &1C, B lane 1 and 3). The PURE system
contains the minimal set of components necessary for in
vitro  protein synthesis, lacking numerous other factors
that are involved in protein synthesis and nascent chain
folding in vivo. A previous study showed that the major E.
coli chaperones were largely absent in the PURE system,
and addition of DnaK family chaperones and trigger fac-
tor to the PURE system enhanced the activity of a synthe-
sized protein [15]. It is possible that the presence of
chaperones in S30 only accounted for the enhanced activ-
ity of already synthesized proteins, whereas the increase in
the overall protein synthesis yield was due to other factors
in S30.
Another interesting difference between the PURE system
and S30 was that protein synthesis in S30 was less affected
by low temperatures than in the PURE system. During the
first 30 min. of protein synthesis, the difference in the ini-
tial accumulation of the activity (and the yield (not
shown)) between 20°C and 37°C was much smaller in
S30 than in the PURE system (Fig. 1C). At 20°C, almost
no activity and protein (not shown) were observed duringBMC Biotechnology 2008, 8:58 http://www.biomedcentral.com/1472-6750/8/58
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the first 30 min. of the synthesis in the PURE system (Fig.
1C). Even after 1 hr at 20°C, only a small amount of Fluc
was detected in the PURE system (Fig. 1A). It is possible
that this cold-sensitivity of the PURE system was due to its
lack of certain cellular factors whose in vivo functions are
to maintain efficient translation after cold shock [16].
Supplementing the PURE system with the E. coli cell 
extract or its fractions improved the yield and activity to a 
level close to that of the S30 system
A S30 extract (Sup), generated from growing E. coli cells,
was fractionated on a size-exclusion column. Each of the
peak fractions (fractions 10 to 21) (Fig. 2) was concen-
trated and then added (10% v/v) to the in vitro synthesis
reactions of the PURE system. The activities were deter-
mined for E. coli β-galactosidase (lacZ) and Fluc. As
shown in Fig. 3A, supplementing fractions 16, 17 and 18
In vitro synthesis of target proteins in different cell-free systems Figure 1
In vitro synthesis of target proteins in different cell-free systems. A. Western blot analysis of in vitro synthesis of Fluc 
at 60 min. at three temperatures in the PURE system (PURE), the S30 and RRL systems. B. Different reporter proteins (indi-
cated) were synthesized for 60 min. in the reactions containing 35S-methionine in the PURE system (lane 1), the PURE system 
supplemented with the fraction 17 (lane 2) and in the S30 system (lane 3). Aliquots of the reactions were run on a SDS-PAGE 
gel, followed by autoradiography. The arrows indicate the positions of the full-length proteins. C. A time course of in vitro syn-
thesis of Fluc in different systems (indicated) and at three temperatures (37°C, filled ovals with solid line; 30°C, open ovals with 
solid line; 20°C, open ovals with dash line). The activities are averages of duplicate experiments and presented as the percent-
age of the relative light unit determined at 37°C and 60 min.
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resulted in a significant enhancement in the activities of
both proteins. The fractions themselves had no detectable
luciferase and galactosidase activity (not shown). The frac-
tion 17 was also shown to enhance the yields of Fluc and
several other proteins (Fig. 1B, lane 2).
The effects of the fraction 17 (F17) and the extract (Sup)
on the amount of synthesized Fluc in the PURE system
were compared with two other commercial S30 systems
(Fig. 3B). The addition of the fraction (F17) or the extract
(Sup) significantly increased the in vitro synthesis yields in
the PURE system to a level close to those of the S30 sys-
tems (Fig. 3B).
The SDS-PAGE gel analysis of the peak fractions suggested
that the fractions 16 to 18 contained the bulk of the E. coli
soluble proteins, consistent with their size range of ~10–
150 kDa (Fig. 2). The data indicated that the "active ingre-
dients" were likely to be macromolecules such as proteins,
but not the small molecules, which were eluted at later
fractions (data not shown). These "active" macromole-
cules could include those already present in the PURE sys-
tem, such as translation factors, chaperones, and those
lacking in the PURE system, such as other cellular factors
that are important for efficient protein synthesis. Consist-
ent with this notion, supplementing the PURE system
reactions with F17 or Sup also significantly enhanced the
protein synthesis yields at 20°C (data not shown). Since
the PURE system is a coupled transcription/translation
system, it is also possible that in vitro transcription was
affected in such a way that protein translation was
enhanced [17].
Supplementing the S30 system with the rabbit reticulocyte 
lysate or its fractions failed to produce an active full-length 
fusion protein
There was no significant difference in the specific activity
(the activity normalized by the yield) when Fluc was syn-
thesized in either S30 or RRL at 37°C (Fig. 1A and 1C).
However, when a fusion protein (FG), consisting of the
Fluc and GFP domains, was synthesized, drastic differ-
ences were observed (Fig. 4). No significant amount of the
full-length fusion protein and almost no activity were
observed in S30, whereas the full-length fusion protein
and the Fluc activity were evident in RRL (Fig. 4A &4B). It
seemed that the Fluc domain in FG was correctly folded
when synthesized in RRL, but not in S30. This appeared to
be due to the GFP domain, since another fusion protein
(F-SH), which had a similar size as FG and consisted of the
SDS-PAGE analysis of the peak fractions (10 to 21) from the size-exclusion separation of an S30 extract Figure 2
SDS-PAGE analysis of the peak fractions (10 to 21) from the size-exclusion separation of an S30 extract. The 
molecular weight standards for the SDS-PAGE are indicated on the left. Based on the molecular weight standards for the size 
exclusion column, fractions 9–11 are >700 kDa; fractions 12–13 are 600–200 kDa; fractions 14–20 are 200–10 kDa.
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Fluc and the SH2–SH3 domains, was successfully synthe-
sized in both S30 and RRL (Fig. 4A, right panel).
To investigate if the ability of RRL to synthesize the full-
length FG was due to its translation or its folding machin-
eries, S30 was supplemented with a crude rabbit reticulo-
cyte lysate, resulting in a mixed system (S30+RRL).
Cycloheximide, an antibiotic specific to the eukaryotic
translation, was added to S30+RRL to prevent any residual
translation from the eukaryotic ribosomes. S30+RRL was
capable of synthesizing the full-length and active Fluc
(Fig. 4A &4B). It appeared that in S30+RRL, protein trans-
lation occurred on the bacterial ribosomes, as the trun-
cated Fluc product, seen only in S30, was also observed in
S30+RRL (Fig. 4A, left panel). In addition, the protein syn-
thesis in S30+RRL was sensitive to the inhibition by chlo-
ramphenicol, an antibiotic specific to prokaryotes (data
not shown). It was apparent that the prokaryotic transla-
tion machinery was fully functional in S30+RRL, and
under such conditions, the nascent chains from the E. coli
ribosomes could be the substrates for folding by the
eukaryotic chaperones present in the rabbit reticulocyte
lysate supplement. However, when the fusion protein FG
was synthesized in S30+RRL, no significant amount of the
The effect of the size-separated fractions on in vitro protein synthesis Figure 3
The effect of the size-separated fractions on in vitro protein synthesis. A. Screening the fractions (10 to 21) from a 
size-exclusion separation of an S30 extract for enhancement in in vitro protein synthesis in the PURE system. The activities 
were assayed at 60 min. for Fluc (grey bars) and β-galactosidase (black bars), and by comparing to the activities of the controls 
(supplemented with only the column buffer), the data are presented as "fold increase". B. Comparison of the protein synthesis 
yields of Fluc between the PURE system (PURE) without any supplement (Buffer) or supplemented with the fraction 17 (F17) 
or the S30 extract (Sup), with the S30 systems from Invitrogen (Expressway) and Roche (RTS). The yields were calculated 
from the activities of the in vitro synthesis reactions compared to that of the known amount of pure Fluc protein assayed at the 
same time.
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full-length FG and almost no Fluc activity were detected
(Fig. 4A, middle panel, and 4B). This result remained the
same whether the crude RRL (Pel-Freez) or the RRL from
the in vitro protein synthesis kit (Promega), which pre-
sumably contained functional eukaryotic chaperones, was
used as the supplement (data not shown). Lowering the
temperatures (to 30°C or 23°C) to slow down the rate of
translation from the E. coli ribosomes failed to make any
difference in the case of FG in both S30 and S30+RRL
(data not shown). In fact, the elongation rate of transla-
tion in S30 has been estimated to be similar to that of
eukaryotic translation [18].
Previous studies suggest that in eukaryotes sequential and
co-translational folding of a fusion protein allows correct
folding of its constituent domains, whereas in prokaryo-
tes, the post-translational folding of the same fusion pro-
tein results in intramolecular misfolding due to
concurrent domain folding [19]. The reason may be that
eukaryotic chaperones are uniquely recruited to the trans-
lating ribosomes to ensure that translation and nascent
In vitro synthesis of the fusion protein FG Figure 4
In vitro synthesis of the fusion protein FG. A. Western blot analyses (anti-Fluc) of the in vitro synthesis reactions (at 60 
min.) of Fluc, FG and F-SH in different systems. The full-length proteins, indicated by arrows, were confirmed by using the puri-
fied proteins of Fluc (purified Fluc) and FG (purified FG). B. The Fluc activities were determined for the Fluc and FG templates 
after 60 min. of the in vitro synthesis reactions in different systems. The data are presented as the relative activities with the 
activity of Fluc in S30 at 60 min being 100. C. Western blot analyses of the time courses of the in vitro synthesis reactions of FG 
in S30+RRL and RRL using anti-Fluc and anti-GFP to probe the translation products. The positions of the full-length FG and 
Fluc, indicated by arrows, were confirmed by the purified FG (purified FG) and the in vitro synthesis reaction of Fluc (FLuc con-
trol). The molecular weights (kDa) are indicated at the left.
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chain folding are coordinated [12,20]. Consistent with
these studies, we detected several known eukaryotic chap-
erones by western blot in the fractions of RRL after a size-
exclusion chromatography (Fig. 5). It was surprising that
these chaperones were mostly not in the fractions that cor-
responded to their molecular weights, but in those of
much larger molecular weights and in those containing
ribosomes (Fig. 5) [21]. None of these fractions when sup-
plemented in S30 had a significant effect on the synthesis
of Fluc or FG (data not shown). It is possible that eukary-
otic chaperones are effective in nascent chain folding only
when protein translation occurs on eukaryotic ribosomes.
Western blot analyses of the in vitro synthesis reactions of
FG in S30 or S30+RRL using anti-Fluc revealed a large
number of products corresponded to a wide range of
molecular weights shorter than the full length FG (Fig.
4C). These incomplete Fluc products were largely not seen
in RRL (Fig. 4C). When anti-GFP was used to probe these
products, only those with molecular weights larger than
Fluc were detected, whereas those smaller than Fluc were
not (Fig. 4C). These data suggest that these smaller trun-
cated translation products were likely the result of prema-
ture termination or pausing during translation, not the
degradation products of the synthesized full-length fusion
proteins. Similar results were also observed by other stud-
ies [22].
Why did a large number of the elongating ribosomes in
S30 or S30+RRL stop on the template of FG even before
the full-length Fluc was synthesized (Fig. 4C), even
though most ribosomes were capable of completing the
synthesis on the templates of Fluc (Fig. 4A, left panel) and
a fusion protein F-SH (Fig. 4A, right panel)? Since both
the Fluc and GFP genes can be readily expressed on their
own in S30 (Fig 1B), we speculate one possibility is that
the sequence of GFP when fused to that of Fluc created a
complex template, e.g., potential inhibitory structures on
the mRNA template, or uniquely misfolded nascent chain,
causing the E. coli ribosomes to pause or terminate prema-
turely, often even before the upstream Fluc domain was
translated. The presence of eukaryotic chaperones or other
factors has no effect as long as the translation was from
the E. coli ribosomes (Fig. 4C). The eukaryotic ribosomes,
perhaps with their associated chaperones and other fac-
tors, seemed to have the ability to overcome these obsta-
cles.
Conclusion
In vitro protein synthesis was compared not only between
the minimal PURE system and the extract-based system,
but also between the prokaryotic and eukaryotic systems.
The advantage of the in vitro approach allowed us to sup-
plement one system with the lysates or their fractions
from another system, thereby providing insights to the
fundamental differences between these systems. Since
ribosomes, translation factors and aminoacyl-tRNA syn-
thetases are among the most conserved RNA and protein
molecules, the PURE system may resemble an ancestral
form of the minimal protein translation machinery,
which, as this study suggests, is sufficient but not efficient
in protein synthesis. The S30 system by comparison con-
tains the modern bacterial version, with additional cellu-
lar factors capable of enhancing protein translation and
folding. The eukaryotic translation machinery may have
evolved from its prokaryotic counterpart in order to trans-
late more complex (difficult-to-translate) templates into
active proteins.
Methods
Materials
The reagents for making the constructs of Fluc and the
fusion proteins were from New England Biolabs. All anti-
bodies against chaperones were purchased from Stress-
Analysis of rabbit reticulocyte lysate by size separation and  western blotting Figure 5
Analysis of rabbit reticulocyte lysate by size separa-
tion and western blotting. Top, SDS-PAGE analysis of the 
peak fractions (9 to 18) from the size-exclusion separation of 
a crude rabbit reticulocyte lysate. The molecular weight 
standards for the SDS-PAGE are indicated on the left. Based 
on the molecular weight standards for the size exclusion col-
umn, fractions 9–11 are >700 kDa; fractions 12–13 are 600–
200 kDa; fractions 14–20 are 200–10 kDa. Bottom, western 
blot analyses of these fractions (9–18) using antibodies 
against Hsp70/Hsc70, Hsp40, Hsp90a and TCP-1a.
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Gen Bioreagents (Ann Arbor, MI). Monoclonal anti-Fluc
and anti-GFP antibodies, cycloheximide, and chloram-
phenicol were purchased from Sigma. The S30 system and
the RRL system were purchased from Promega except
when indicated otherwise. Other S30 systems used were
Expressway (Invitrogen) and the RTS system (Roche bio-
sciences). A crude rabbit reticulocyte lysate was purchased
from Pel-Freez Biologicals (Rogers, AR). The PURE system
(Classic II) was purchased from Post Genome Institute
(Tokyo, Japan). 35S-methionine (37 Tbq/mmol) was from
Amersham.
Plasmid constructs of the reporter proteins
The genes for firefly luciferase (61 kDa) (Fluc), Aequorea
victoria GFP (27 kDa), and E. coli β-galactosidase (116
kDa) (lacZ) were cloned into a pUC19-derived vector con-
taining a T7 promoter and a bacterial Shine-Dalgarno
sequence. The vector for in vitro synthesis of E. coli dihy-
drofolate reductase (DHFR) was a control vector in the
PURE system kit. The fusion protein FG (88 kDa) was con-
structed by fusing the N-terminus of GFP to the C-termi-
nus of Fluc. Another fusion protein F-SH (81 kDa)
consisted of the SH2–SH3 domain of human p120 (GAP)
protein fused to the C-terminus of Fluc.
In vitro protein synthesis reactions
All reactions were conducted following the recommended
protocols by the manufacturers of the in vitro systems. All
S30 systems were used in batch mode. 400–500 ng of the
plasmid DNA was used for each 50 μl reaction. For 35S
labeling, 4 μl 35S-methionine was added per 50 μl reac-
tion. For the PURE system reactions containing the sup-
plements, 2.5 μl of the S30 extract (Sup) or the
concentrated fraction was used for each 25 μl reaction.
The S30 extract was prepared from an exponentially grow-
ing E. coli strain according to the protocol of Zubay [11]
and obtained from the laboratory of Chris Noren (New
England Biolabs). For in vitro reactions in a mixed system
(S30+RRL), 10 μl of the rabbit reticulocyte lysate from
Pel-Freez or Promega and 2 ng/μl cycloheximide was
added to the S30 reaction mixture in a final volume of 50
μl.
Activity assays
The Fluc activity was assayed using the Luciferase Assay
System (Promega) and a microplate luminometer (Centro
LB 640, Berthold Technologies). The same luminometer
was also used to assay the lacZ activity in combination
with the Galacto-Light™ system (Applied Biosystems).
Analysis of the synthesized proteins
Aliquots (1 μl for the western blot analyses or 5 μl for 35S
labeling) were taken from the in vitro reactions and loaded
on 10–20% Tris-glycine SDS PAGE gels (Invitrogen). The
gels were either blotted for analyses with antibodies or
dried for exposure to X-ray films.
Size-exclusion chromatography
For fractionation of the S30 extract, 1 ml of the extract
(~12 mg/ml protein) in the column buffer (20 mM
HEPES, pH 7.6, 50 mM KCl, 1 mM DTT) was loaded onto
a Superdex 200 (10/300) column (Pharmacia). The frac-
tions were collected and then concentrated 5–10 fold in
Centricon tubes (Milipore). For fractionation of the crude
rabbit reticulocyte lysate, 1 ml of the lysate in the RRL col-
umn buffer (30 mM HEPES, pH 7.2, 10 mM NaCl, 1 mM
MgCl2, 0.1 mM EDTA, 25 mM KOAc, and 0.2 mM DTT)
was loaded on the same column. The fractions were
directly used for western blot analyses.
Abbreviations
S30: an E. coli extract-based in vitro protein synthesis sys-
tem; RRL: rabbit reticulocyte lysate or rabbit reticulocyte
lysate-based in vitro protein synthesis system; S30+RRL:
S30 supplemented with RRL; The PURE system: a recon-
stituted in vitro protein synthesis system based on protein
translation in E. coli; Fluc: firefly luciferase; GFP: green flu-
orescent protein;
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